Aptose Biosciences (APS) Stock Chart & Stock Price History C$0.55 +0.02 (+3.77%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades Aptose Biosciences Stock Price Performance5 Day Performance0.00%1 Month Performance+10.00%3 Month Performance-16.67%6 Month Performance-66.46%Year-To-Date Performance-83.58%1 Year Performance-86.81% Receive APS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Timothy SykesTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade APS Stock Chart for Tuesday, November, 5, 2024 APS Chart by TradingView Aptose Biosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024C$0.53C$0.55+3.77%C$0.55C$0.5313,154 shsC$9.96 million11/01/2024C$0.52C$0.53+1.92%C$0.55C$0.524,100 shsC$9.60 million10/31/2024C$0.55C$0.52-5.45%C$0.52C$0.521,800 shsC$9.42 million10/30/2024C$0.54C$0.55+1.85%C$0.55C$0.523,520 shsC$9.96 million10/29/2024C$0.50C$0.54+8.00%C$0.54C$0.513,350 shsC$9.78 million10/28/2024C$0.52C$0.50-3.85%C$0.53C$0.505,500 shsC$9.06 million Get the Latest News and Ratings for APS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024C$0.55C$0.52-5.45%C$0.55C$0.525,134 shsC$9.42 million10/24/2024C$0.55C$0.55C$0.55C$0.559,000 shsC$9.96 million10/23/2024C$0.54C$0.55+1.85%C$0.55C$0.559,000 shsC$9.96 million10/22/2024C$0.55C$0.54-1.82%C$0.55C$0.549,022 shsC$9.78 million10/21/2024C$0.55C$0.55C$0.55C$0.551,002 shsC$9.96 million10/18/2024C$0.50C$0.55+10.00%C$0.56C$0.514,570 shsC$9.96 million10/17/2024C$0.49C$0.50+3.09%C$0.50C$0.501,500 shsC$9.06 million10/16/2024C$0.50C$0.49-3.00%C$0.50C$0.496,510 shsC$8.78 million10/15/2024C$0.49C$0.50+2.04%C$0.50C$0.498,575 shsC$9.06 million10/14/2024C$0.49C$0.49C$0.50C$0.494,000 shsC$8.87 million10/11/2024C$0.49C$0.49C$0.50C$0.494,000 shsC$8.87 million10/10/2024C$0.49C$0.49C$0.50C$0.494,799 shsC$8.87 million10/09/2024C$0.48C$0.49+2.08%C$0.51C$0.493,000 shsC$8.87 million10/08/2024C$0.49C$0.48-2.04%C$0.50C$0.4716,109 shsC$8.69 million10/07/2024C$0.50C$0.49-2.00%C$0.51C$0.499,683 shsC$8.87 million10/04/2024C$0.51C$0.50-1.96%C$0.52C$0.507,520 shsC$9.06 million10/03/2024C$0.53C$0.51-3.77%C$0.52C$0.511,510 shsC$9.24 million10/02/2024C$0.53C$0.53C$0.56C$0.532,486 shsC$9.60 million10/01/2024C$0.53C$0.53C$0.56C$0.533,280 shsC$9.60 million09/30/2024C$0.56C$0.53-5.36%C$0.56C$0.532,515 shsC$9.60 million09/27/2024C$0.55C$0.56+1.82%C$0.56C$0.553,833 shsC$10.14 million09/26/2024C$0.55C$0.55C$0.55C$0.534,092 shsC$9.96 million09/25/2024C$0.53C$0.55+3.77%C$0.55C$0.539,000 shsC$9.96 million09/24/2024C$0.54C$0.53-1.85%C$0.56C$0.531,900 shsC$9.60 million09/23/2024C$0.54C$0.54C$0.54C$0.532,002 shsC$9.78 million09/20/2024C$0.54C$0.54C$0.57C$0.548,000 shsC$9.78 million09/19/2024C$0.53C$0.54+1.89%C$0.57C$0.549,542 shsC$9.78 million09/18/2024C$0.53C$0.53C$0.53C$0.531,544 shsC$9.60 million09/17/2024C$0.52C$0.53+1.92%C$0.58C$0.523,000 shsC$9.60 million09/16/2024C$0.50C$0.52+4.00%C$0.56C$0.5211,301 shsC$9.42 million09/13/2024C$0.48C$0.50+4.17%C$0.50C$0.4820,578 shsC$9.06 million09/12/2024C$0.49C$0.48-1.03%C$0.49C$0.482,050 shsC$8.69 million09/11/2024C$0.50C$0.49-2.02%C$0.49C$0.494,555 shsC$8.78 million09/10/2024C$0.47C$0.50+5.32%C$0.50C$0.4617,400 shsC$8.96 millionTim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…Click here to see a unique election-year trade09/09/2024C$0.52C$0.47-9.62%C$0.50C$0.479,471 shsC$8.51 million09/06/2024C$0.51C$0.52+1.96%C$0.52C$0.4812,430 shsC$9.42 million09/05/2024C$0.52C$0.51-1.92%C$0.54C$0.5110,071 shsC$9.24 million09/04/2024C$0.56C$0.52-7.14%C$0.55C$0.5010,950 shsC$9.42 million09/03/2024C$0.53C$0.56+5.66%C$0.63C$0.4825,792 shsC$10.14 million09/02/2024C$0.53C$0.53C$0.58C$0.535,203 shsC$9.60 million08/30/2024C$0.53C$0.53C$0.58C$0.535,205 shsC$9.60 million08/29/2024N/AC$0.53C$0.53C$0.53804 shsC$9.60 million08/27/2024C$0.53C$0.53C$0.57C$0.525,900 shsC$9.60 million08/26/2024C$0.53C$0.53C$0.58C$0.533,998 shsC$9.60 million08/23/2024C$0.55C$0.53-3.64%C$0.53C$0.531,013 shsC$9.60 million08/22/2024C$0.65C$0.55-15.38%C$0.62C$0.5518,361 shsC$9.96 million08/21/2024C$0.65C$0.65C$0.65C$0.6530,003 shsC$11.77 million08/20/2024C$0.64C$0.65+1.56%C$0.68C$0.653,174 shsC$11.77 million08/19/2024C$0.60C$0.64+6.67%C$0.67C$0.643,225 shsC$11.59 million08/16/2024C$0.70C$0.60-14.29%C$0.65C$0.602,501 shsC$10.87 million08/15/2024C$0.66C$0.70+6.06%C$0.70C$0.674,500 shsC$12.68 million08/14/2024C$0.67C$0.66-1.49%C$0.70C$0.6611,268 shsC$11.95 million08/13/2024C$0.67C$0.67C$0.67C$0.673,060 shsC$12.13 million08/12/2024C$0.71C$0.67-5.63%C$0.71C$0.676,607 shsC$12.13 million08/09/2024C$0.79C$0.71-10.13%C$0.77C$0.712,000 shsC$11.58 million08/08/2024C$0.68C$0.79+16.18%C$0.79C$0.6923,500 shsC$12.89 million08/07/2024C$0.65C$0.68+4.62%C$0.69C$0.677,033 shsC$11.09 million08/06/2024C$0.66C$0.65-1.52%C$0.66C$0.6018,314 shsC$10.60 million08/05/2024C$0.66C$0.66C$0.70C$0.656,495 shsC$10.77 million Related Companies RVX Stock Chart CZO Stock Chart KNE Stock Chart GSD Stock Chart AEZS Stock Chart SBM Stock Chart HEM Stock Chart IOT Stock Chart QPT Stock Chart FRX Stock Chart Receive APS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (TSE:APS) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredThe Death Knell for U.S. StocksThey are among the 31 billionaires dumping their stocks at a record pace. Fortune calls this phenomenon "Th...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptose Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptose Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APS Stock Alerts